Clopidogrel (Plavix) has been the standard antiplatelet therapy for a decade, but it is now facing challenges with ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
February 16, 2011 โ The newly approved drug dabigatran is an alternative to warfarin to help prevent dangerous ...
February 16, 2011
February 10, 2011 โ A Phase 2 clinical trial has been initiated to test the safety and efficacy of drug to reverse ...
February 10, 2011
January 7, 2011 โ A new study from The Ohio State University found that Protandim can suppress intimal ...
January 07, 2011December 29, 2010 - Research on reducing risks, improving medical treatment and improving lifestyle behaviors to ...
December 29, 2010December 29, 2010 โ Patient enrollment has been completed for a Phase III trial of an oral Factor Xa inhibitor ...
December 29, 2010
December 27, 2010 โ The U.S. Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and ...
December 27, 2010December 21, 2010 โ A once-daily, three-in-one combination blood pressure treatment has been approved in Germany ...
December 21, 2010December 17, 2010 โ Data published in Circulation: Cardiovascular Interventions showed that a protein used with ...
December 17, 2010December 17, 2010 - The U.S. Food and Drug Administration (FDA) has requested additional analyses of the trial ...
December 17, 2010
December 15, 2010 โ A guest editorial in the new publication Clinical Investigation highlights dabigatran ...
December 15, 2010December 13, 2010 โ Based on emerging safety information, the pulmonary arterial hypertension (PAH) drug ...
December 13, 2010
November 24, 2010 โ Cardiologists and primary care physicians now perceive AstraZeneca's Crestor as comparable to ...
November 24, 2010November 18, 2010 โ In the trial of 1,623 patients with coronary heart disease (CHD) or CHD risk equivalents, an ...
November 18, 2010November 17, 2010 โ Chronic heart failure patients treated with eplerenone (Inspra) experienced a significant ...
November 17, 2010ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now